Skip to Content

E4/DRSP Approval Status

FDA Approved: No
Brand name: E4/DRSP
Generic name: estetrol and drospirenone
Company: Mayne Pharma US
Treatment for: Birth Control

E4/DRSP (estetrol and drospirenone) is a novel combined hormonal oral contraceptive pill in development for the prevention of pregnancy.

Development Status and FDA Approval Process for E4/DRSP

DateArticle
Jun 24, 2020Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP in the US

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.